Adial Pharmaceuticals Inc (NASDAQ:ADIL) has a beta value of 1.17 and has seen 0.65 million shares traded in the recent trading session. The company, currently valued at $5.59M, closed the recent trade at $0.86 per share which meant it gained $0.03 on the day or 4.16% during that session. The ADIL stock price is -384.88% off its 52-week high price of $4.17 and 16.28% above the 52-week low of $0.72. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.12 million shares traded. The 3-month trading volume is 168.65K shares.
Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information
Sporting 4.16% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ADIL stock price touched $0.86 or saw a rise of 14.84%. Year-to-date, Adial Pharmaceuticals Inc shares have moved -14.41%, while the 5-day performance has seen it change -10.32%. Over the past 30 days, the shares of Adial Pharmaceuticals Inc (NASDAQ:ADIL) have changed -17.67%. Short interest in the company has seen 78882.0 shares shorted with days to cover at 0.65.
Adial Pharmaceuticals Inc (ADIL) estimates and forecasts
Figures show that Adial Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -18.44% over the past 6 months, with this year growth rate of 38.09%, compared to 16.20% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 38.36% over the past 5 years.
ADIL Dividends
Adial Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders
Insiders own 1.80% of the company shares, while shares held by institutions stand at 3.03% with a share float percentage of 3.08%. Investors are also buoyed by the number of investors in a company, with Adial Pharmaceuticals Inc having a total of 13.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Oct 31, 2024, the former fund manager holds about 0.55% shares in the company for having 35.14 shares of worth $29868.0 while later fund manager owns 9.36 shares of worth $7955.0 as of Sep 30, 2024, which makes it owner of about 0.15% of company’s outstanding stock.
